Drawing for FINGRAPH

USPTO serial 79130788

FINGRAPH

Reviewed by CopyMark Law Group

Reg. 4535263Status 404
Filing date
Status date
Registration date
May 27, 2014
Examiner
MIDDLETON, BERNICE L
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with FINGRAPH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael R. Friscia

MICHAEL R. FRISCIA MCCARTER & ENGLISH, LLPFOUR GATEWAY CTR100 MULBERRY STREETNEWARK, NJ 07102

Goods and services

ClassDescriptionStatusFirst use
005Diagnostic reagents for measuring electrolyte in whole blood for medical use or aid for medical purposes; diagnostic preparations for medical purposes; oiled reagent paper for medical purposes; wrapping wafers for dose of medicine sold empty; gauze for dressings; empty capsules for pharmaceuticals; eye patches for medical purposes; ear bandages for medical use; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cotton for medical purposes; adhesive medical plasters; bandages for dressings; liquid dressings, namely, antiseptic liquid bandages; breast-nursing pads; dental composite materials; cotton swabs for medical useSECTION 71 - CANCELLED—
010Diagnostic analyzer for blood analysis using diagnostic reagents for medical use or aid for medical purposes; device for measuring electrolyte in whole blood using diagnostic reagents for medical use or aid for medical purposes; diagnostic apparatus and instruments for medical use or aid for medical purposes, namely, hematology analyzers for medical diagnostic uses; pacifiers for babies; ice bag pillows for medical purposes; triangular bandages, namely, slings; supportive bandages; surgical catguts; feeding cups for medical purposes; dropping pipettes for medical purposes; teats; medical ice bags; medical ice bag holders; baby bottles; vacuum bottles for nursing; finger guards for medical purposes; artificial tympanic membranes; prosthetic or filling materials not for dental use, namely, artificial materials for use in the replacement of bones; sanitary masks for medical useSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 2, 2023DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Sep 2, 2023DETHDEATH OF INTERNATIONAL REGISTRATION—
Mar 20, 2022INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Feb 16, 2022INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Feb 16, 2022INPCINVALIDATION PROCESSED—
Oct 26, 2021INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Feb 26, 2021C71TCANCELLED SECTION 71—
Dec 25, 2020NREPNEW REPRESENTATIVE AT IB RECEIVED—
May 27, 2019REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jun 14, 2018NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 23, 2014FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 9, 2014FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 9, 2014FIMPFINAL DISPOSITION PROCESSED—
Aug 28, 2014ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Aug 27, 2014FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 27, 2014R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 11, 2014NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 11, 2014PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 7, 2014GPNXNOTIFICATION PROCESSED BY IB—
Feb 19, 2014OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 19, 2014OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Feb 19, 2014NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 6, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 27, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 24, 2014XAECEXAMINER'S AMENDMENT ENTERED—
Jan 24, 2014GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 24, 2014GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 24, 2014CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 16, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 16, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 13, 2013ALIEASSIGNED TO LIE—
Nov 11, 2013TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 15, 2013RFNTREFUSAL PROCESSED BY IB—
Jun 26, 2013RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 26, 2013RFRRREFUSAL PROCESSED BY MPU—
Jun 22, 2013RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 21, 2013CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 18, 2013MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 14, 2013DOCKASSIGNED TO EXAMINER—
Jun 14, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 13, 2013REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance